Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain, Postoperative | 6 | 2018 | 205 | 1.640 |
Why?
|
| Spinal Cord | 12 | 2025 | 150 | 1.440 |
Why?
|
| Hyperalgesia | 7 | 2025 | 86 | 1.020 |
Why?
|
| Ganglia, Spinal | 8 | 2025 | 72 | 0.820 |
Why?
|
| Pain | 10 | 2025 | 330 | 0.770 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2018 | 923 | 0.750 |
Why?
|
| Rats | 16 | 2018 | 1946 | 0.710 |
Why?
|
| Sensory Receptor Cells | 4 | 2025 | 37 | 0.690 |
Why?
|
| Animals | 31 | 2025 | 8544 | 0.620 |
Why?
|
| Paclitaxel | 4 | 2020 | 73 | 0.600 |
Why?
|
| Bone Neoplasms | 5 | 2024 | 118 | 0.600 |
Why?
|
| Neuroglia | 3 | 2015 | 32 | 0.590 |
Why?
|
| TRPV Cation Channels | 2 | 2016 | 27 | 0.590 |
Why?
|
| Spinal Nerves | 4 | 2018 | 72 | 0.580 |
Why?
|
| Recovery of Function | 3 | 2018 | 251 | 0.560 |
Why?
|
| Analgesia | 2 | 2015 | 32 | 0.560 |
Why?
|
| Neurons, Afferent | 4 | 2006 | 70 | 0.530 |
Why?
|
| Signal Transduction | 3 | 2024 | 765 | 0.500 |
Why?
|
| Stress, Psychological | 1 | 2018 | 233 | 0.480 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2015 | 35 | 0.460 |
Why?
|
| Peripheral Nervous System Diseases | 3 | 2020 | 54 | 0.450 |
Why?
|
| Capsaicin | 2 | 2014 | 32 | 0.430 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2014 | 5 | 0.420 |
Why?
|
| Anesthetics, Combined | 1 | 2014 | 6 | 0.420 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2014 | 18 | 0.420 |
Why?
|
| Lidocaine | 1 | 2014 | 20 | 0.420 |
Why?
|
| Nerve Block | 1 | 2014 | 63 | 0.400 |
Why?
|
| Antineoplastic Agents, Phytogenic | 3 | 2007 | 37 | 0.380 |
Why?
|
| Pain Measurement | 5 | 2015 | 385 | 0.370 |
Why?
|
| Male | 28 | 2025 | 20697 | 0.370 |
Why?
|
| Disease Models, Animal | 10 | 2018 | 1118 | 0.340 |
Why?
|
| Macrophages | 3 | 2025 | 216 | 0.330 |
Why?
|
| Ondansetron | 1 | 2010 | 5 | 0.330 |
Why?
|
| Analgesics | 2 | 2011 | 117 | 0.320 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2010 | 21 | 0.320 |
Why?
|
| Amines | 1 | 2010 | 24 | 0.320 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 51 | 0.310 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 83 | 0.310 |
Why?
|
| Surgical Procedures, Operative | 1 | 2010 | 79 | 0.300 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2025 | 12 | 0.280 |
Why?
|
| Antineoplastic Agents | 2 | 2025 | 627 | 0.270 |
Why?
|
| Sciatic Nerve | 1 | 2007 | 39 | 0.260 |
Why?
|
| Osteoclasts | 3 | 2025 | 25 | 0.260 |
Why?
|
| Peripheral Nerves | 2 | 2006 | 65 | 0.250 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 23 | 0.250 |
Why?
|
| Receptors, Endothelin | 2 | 2003 | 6 | 0.250 |
Why?
|
| Neural Conduction | 3 | 2020 | 92 | 0.240 |
Why?
|
| Tibial Nerve | 2 | 2020 | 22 | 0.240 |
Why?
|
| Neuropeptides | 1 | 2025 | 23 | 0.230 |
Why?
|
| Carboplatin | 1 | 2025 | 55 | 0.230 |
Why?
|
| Behavior, Animal | 4 | 2015 | 303 | 0.230 |
Why?
|
| Polyneuropathies | 1 | 2005 | 11 | 0.220 |
Why?
|
| Activating Transcription Factor 3 | 5 | 2025 | 7 | 0.220 |
Why?
|
| Mice | 10 | 2025 | 2691 | 0.210 |
Why?
|
| Spinal Cord Ischemia | 1 | 2003 | 2 | 0.200 |
Why?
|
| Gliosis | 1 | 2003 | 6 | 0.200 |
Why?
|
| Physical Stimulation | 3 | 2014 | 89 | 0.190 |
Why?
|
| Glial Fibrillary Acidic Protein | 5 | 2014 | 44 | 0.190 |
Why?
|
| Spinal Cord Injuries | 1 | 2003 | 47 | 0.190 |
Why?
|
| Disease Progression | 1 | 2024 | 633 | 0.180 |
Why?
|
| Cell Proliferation | 1 | 2024 | 628 | 0.180 |
Why?
|
| Radiosurgery | 1 | 2025 | 360 | 0.180 |
Why?
|
| Nociceptors | 3 | 2014 | 45 | 0.170 |
Why?
|
| Time Factors | 5 | 2015 | 2352 | 0.170 |
Why?
|
| Dependovirus | 2 | 2017 | 20 | 0.160 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 4 | 2007 | 21 | 0.160 |
Why?
|
| Nerve Fibers | 3 | 2020 | 40 | 0.160 |
Why?
|
| Antigens, CD | 4 | 2007 | 106 | 0.160 |
Why?
|
| Sural Nerve | 1 | 2020 | 28 | 0.160 |
Why?
|
| Taxoids | 1 | 2020 | 60 | 0.160 |
Why?
|
| Median Nerve | 1 | 2020 | 53 | 0.150 |
Why?
|
| Injections, Spinal | 4 | 2018 | 124 | 0.150 |
Why?
|
| RNA, Messenger | 2 | 2018 | 545 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 1523 | 0.140 |
Why?
|
| Receptors, Vasopressin | 1 | 2018 | 6 | 0.140 |
Why?
|
| Receptors, Oxytocin | 1 | 2018 | 8 | 0.140 |
Why?
|
| Pruritus | 2 | 2015 | 47 | 0.140 |
Why?
|
| Psychology | 1 | 2018 | 25 | 0.140 |
Why?
|
| Thalamus | 1 | 2018 | 39 | 0.140 |
Why?
|
| Oxytocin | 2 | 2018 | 31 | 0.140 |
Why?
|
| Up-Regulation | 2 | 2016 | 202 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 107 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 66 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 129 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2020 | 417 | 0.130 |
Why?
|
| Genetic Vectors | 1 | 2017 | 127 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2017 | 99 | 0.130 |
Why?
|
| Femoral Fractures | 2 | 2007 | 48 | 0.130 |
Why?
|
| Nerve Growth Factor | 2 | 2007 | 5 | 0.130 |
Why?
|
| Receptors, Opioid | 1 | 2016 | 14 | 0.130 |
Why?
|
| Chemokines | 1 | 2016 | 36 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2016 | 143 | 0.120 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2015 | 1 | 0.120 |
Why?
|
| Receptors, Bombesin | 1 | 2015 | 3 | 0.120 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 2015 | 4 | 0.120 |
Why?
|
| Arvicolinae | 1 | 2015 | 2 | 0.120 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2015 | 35 | 0.120 |
Why?
|
| Locus Coeruleus | 1 | 2015 | 23 | 0.120 |
Why?
|
| Ligation | 2 | 2018 | 65 | 0.120 |
Why?
|
| Receptors, Opioid, mu | 1 | 2015 | 36 | 0.120 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2015 | 26 | 0.120 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 89 | 0.120 |
Why?
|
| Imidazoles | 1 | 2015 | 97 | 0.110 |
Why?
|
| Pyramidal Tracts | 1 | 2015 | 3 | 0.110 |
Why?
|
| Mice, Inbred C3H | 5 | 2007 | 35 | 0.110 |
Why?
|
| Glutamic Acid | 1 | 2015 | 50 | 0.110 |
Why?
|
| Neuralgia | 1 | 2015 | 47 | 0.110 |
Why?
|
| Astrocytes | 2 | 2007 | 64 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 2 | 2007 | 270 | 0.110 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2014 | 35 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2015 | 182 | 0.110 |
Why?
|
| Sensory System Agents | 1 | 2014 | 9 | 0.110 |
Why?
|
| Mechanoreceptors | 1 | 2014 | 43 | 0.100 |
Why?
|
| Oxytocics | 1 | 2014 | 14 | 0.100 |
Why?
|
| Nerve Growth Factors | 2 | 2018 | 16 | 0.100 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 526 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 803 | 0.100 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 96 | 0.100 |
Why?
|
| Inflammation | 1 | 2016 | 557 | 0.100 |
Why?
|
| Female | 9 | 2024 | 21490 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 934 | 0.090 |
Why?
|
| Microglia | 2 | 2016 | 66 | 0.090 |
Why?
|
| Norepinephrine | 1 | 2011 | 103 | 0.090 |
Why?
|
| Quinolizines | 1 | 2010 | 3 | 0.080 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2010 | 4 | 0.080 |
Why?
|
| Serotonin Antagonists | 1 | 2010 | 9 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2010 | 29 | 0.080 |
Why?
|
| Indoles | 1 | 2010 | 67 | 0.080 |
Why?
|
| Hindlimb | 1 | 2010 | 55 | 0.080 |
Why?
|
| Injections, Intravenous | 2 | 2006 | 101 | 0.080 |
Why?
|
| Posterior Horn Cells | 2 | 2006 | 11 | 0.070 |
Why?
|
| Brain | 1 | 2015 | 1031 | 0.070 |
Why?
|
| Injections, Intraventricular | 1 | 2007 | 18 | 0.070 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2007 | 12 | 0.070 |
Why?
|
| Cell Size | 1 | 2007 | 43 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 138 | 0.060 |
Why?
|
| Sarcoma | 2 | 2005 | 74 | 0.060 |
Why?
|
| Satellite Cells, Perineuronal | 1 | 2006 | 1 | 0.060 |
Why?
|
| Schwann Cells | 1 | 2006 | 6 | 0.060 |
Why?
|
| Trigeminal Ganglion | 1 | 2006 | 1 | 0.060 |
Why?
|
| Receptor, Endothelin B | 2 | 2003 | 5 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 72 | 0.060 |
Why?
|
| RANK Ligand | 1 | 2025 | 6 | 0.060 |
Why?
|
| Macaca fascicularis | 2 | 2018 | 548 | 0.060 |
Why?
|
| Femoral Neoplasms | 1 | 2005 | 4 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2025 | 201 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2005 | 42 | 0.060 |
Why?
|
| Models, Biological | 1 | 2007 | 426 | 0.060 |
Why?
|
| Osteolysis | 1 | 2004 | 8 | 0.050 |
Why?
|
| Alendronate | 1 | 2004 | 11 | 0.050 |
Why?
|
| Humans | 4 | 2024 | 34474 | 0.050 |
Why?
|
| Receptor, Endothelin A | 1 | 2003 | 4 | 0.050 |
Why?
|
| Optic Nerve Injuries | 1 | 2003 | 2 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2025 | 484 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2003 | 36 | 0.050 |
Why?
|
| Optic Nerve | 1 | 2003 | 17 | 0.050 |
Why?
|
| Osteosarcoma | 1 | 2002 | 11 | 0.050 |
Why?
|
| Pain Threshold | 2 | 2014 | 105 | 0.050 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2002 | 5 | 0.050 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2002 | 6 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 72 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 40 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 62 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 51 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 772 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2003 | 94 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 163 | 0.050 |
Why?
|
| Epidermis | 1 | 2020 | 30 | 0.040 |
Why?
|
| Ankle | 1 | 2020 | 32 | 0.040 |
Why?
|
| Albumins | 1 | 2020 | 47 | 0.040 |
Why?
|
| Electrodiagnosis | 1 | 2020 | 42 | 0.040 |
Why?
|
| Forearm | 1 | 2020 | 49 | 0.040 |
Why?
|
| Wrist | 1 | 2020 | 50 | 0.040 |
Why?
|
| Leg | 1 | 2020 | 71 | 0.040 |
Why?
|
| Neurons | 1 | 2002 | 491 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2018 | 30 | 0.030 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 2 | 2011 | 6 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 583 | 0.030 |
Why?
|
| Immunotoxins | 2 | 2011 | 18 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 74 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 269 | 0.030 |
Why?
|
| Radiography | 2 | 2007 | 397 | 0.030 |
Why?
|
| Bombesin | 1 | 2015 | 4 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2015 | 11 | 0.030 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2015 | 4 | 0.030 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2015 | 4 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 2015 | 8 | 0.030 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2015 | 18 | 0.030 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Autoradiography | 1 | 2015 | 55 | 0.030 |
Why?
|
| Skin | 1 | 2017 | 222 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2018 | 529 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1607 | 0.030 |
Why?
|
| Proton Pumps | 1 | 2014 | 7 | 0.030 |
Why?
|
| Neurofilament Proteins | 1 | 2014 | 17 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2014 | 48 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2014 | 80 | 0.030 |
Why?
|
| Toxicity Tests, Chronic | 1 | 2014 | 4 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 2461 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 73 | 0.030 |
Why?
|
| Dogs | 1 | 2014 | 130 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 508 | 0.020 |
Why?
|
| Random Allocation | 1 | 2014 | 257 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 306 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 265 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2015 | 429 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 755 | 0.020 |
Why?
|
| Anterior Horn Cells | 1 | 2011 | 2 | 0.020 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2011 | 5 | 0.020 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2011 | 5 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2011 | 11 | 0.020 |
Why?
|
| Tritium | 1 | 2011 | 19 | 0.020 |
Why?
|
| Atropine | 1 | 2011 | 23 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2011 | 17 | 0.020 |
Why?
|
| Heart Rate | 1 | 2014 | 372 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 49 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2011 | 66 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 38 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2011 | 40 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2011 | 69 | 0.020 |
Why?
|
| Clonidine | 1 | 2011 | 66 | 0.020 |
Why?
|
| Quality of Life | 1 | 2016 | 1032 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 901 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 2366 | 0.020 |
Why?
|
| Dynorphins | 1 | 2007 | 8 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2007 | 13 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2007 | 28 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2007 | 19 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2007 | 45 | 0.020 |
Why?
|
| Antibodies | 1 | 2007 | 59 | 0.020 |
Why?
|
| Femur | 1 | 2007 | 82 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 10998 | 0.020 |
Why?
|
| Lumbosacral Region | 1 | 2006 | 13 | 0.020 |
Why?
|
| Wound Healing | 1 | 2007 | 190 | 0.020 |
Why?
|
| Thorax | 1 | 2006 | 31 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 12703 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 180 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 834 | 0.010 |
Why?
|
| Necrosis | 1 | 2004 | 54 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 192 | 0.010 |
Why?
|
| Hyperostosis | 1 | 2002 | 1 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 17 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 32 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2002 | 16 | 0.010 |
Why?
|
| Plant Proteins | 1 | 2002 | 15 | 0.010 |
Why?
|
| Cytotoxins | 1 | 2002 | 13 | 0.010 |
Why?
|
| Substance P | 1 | 2002 | 23 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 51 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 99 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 231 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 593 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 3618 | 0.010 |
Why?
|